Recapitulating folliculogenesis and oogenesis outside the body: encapsulated in vitro follicle growth
Biology of Reproduction · 14.01.2023 · 108 (1) · 5-22
DOI: 10.1093/biolre/ioac176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of Reproduction, online erschienen am 22.09.2022. Verfasst von Aubrey Converse und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illnois, USA. Hauptthemen laut MEDLINE: Ovarian Follicle, Oogenesis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Bill & Melinda Gates Foundation, NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Folliculogenesis is a tightly coordinated process essential for generating a fertilization-competent gamete while also producing gonadal hormones that sustain endocrine function. In vitro follicle growth systems have been critical to our understanding of key events in folliculogenesis, such as gonadotropin-independent and dependent growth, steroid hormone production, and oocyte growth and maturation (cytoplasmic and meiotic). Although there are several successful follicle culture strategies, the following protocol details an encapsulated in vitro follicle growth (eIVFG) system for use with mouse ovarian follicles. Encapsulated IVFG is performed with alginate hydrogels, which are biologically inert, maintains cell-to-cell interactions between granulosa cells and the oocyte, and preserves follicle architecture as found in the ovary. The system supports follicle growth, development, and differentiation from the early primary follicle to the antral follicle stage. Moreover, post-folliculogenesis events including meiotic maturation, ovulation, and luteinization are also supported. Importantly, the culture of secondary follicles has successfully resulted in viable pups after blastocyst transfer. This alginate-based eIVFG system is versatile and has broad applications as a tool for interrogating the fundamental biology of the ovarian follicle in a controlled manner, a screening platform for toxicity and bioactivity, and a potential fertility preservation method for endangered species as well as humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illnois, USA.
Förderung
- Bill & Melinda Gates Foundation
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Converse, A., Zaniker, E. J., Amargant, F., & Duncan, F. E. (2023). Recapitulating folliculogenesis and oogenesis outside the body: encapsulated in vitro follicle growth. Biology of Reproduction, 108(1), 5-22. https://doi.org/10.1093/biolre/ioac176
Vancouver
Converse A, Zaniker EJ, Amargant F, Duncan FE. Recapitulating folliculogenesis and oogenesis outside the body: encapsulated in vitro follicle growth. Biology of Reproduction. 2023;108(1):5-22. doi:10.1093/biolre/ioac176
BibTeX
@article{Converse2023,
author = {Converse, Aubrey and Zaniker, Emily J and Amargant, Farners and Duncan, Francesca E},
title = {Recapitulating folliculogenesis and oogenesis outside the body: encapsulated in vitro follicle growth},
journal = {Biology of Reproduction},
year = {2023},
volume = {108},
number = {1},
pages = {5--22},
doi = {10.1093/biolre/ioac176}
}
EUVIMED